$GERN
Geron Corp
XNAS•Health Care•Pharmaceutical Preparations
Geron Corp
XNAS•Health Care•Pharmaceutical Preparations
Why is GERN down today? It is at $0.906, -0.81% on the day and -0.81% pre-market, and our scanner flagged it 202 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GERN spikes, and full due diligence on GERN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GERN 202 times in the last 30 days. Create a free account to track $GERN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on GERN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GERN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystGERON CORP: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 16, 2026 · 3 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Williams Timothy Officer | Bought (open market) | +12K | n/a | 12K | $11K at $0.940 | Nov 16, 26 |
Semerjian Harout Officer | Bought (open market) | +54K | n/a | 54K | $51K at $0.950 | Nov 13, 26 |
Spiegel Robert J. Director | Acquired (grant/award) | +6K | added 3.1% | 212K | $8K at $1.23 | Sep 30, 26 |
Spiegel Robert J. Director | Acquired (grant/award) | +6K | added 3.1% | 206K | $8K at $1.28 | Jun 30, 26 |
Spiegel Robert J. Director | Acquired (grant/award) | +5K | added 2.7% | 200K | $8K at $1.49 | Mar 31, 26 |
Robertson Michelle Officer | Sold (automatic/other) | -10K | sold 36% | 18K | $19K at $1.94 | Feb 18, 26 |
Robertson Michelle Officer | Other | 28K | n/a | 28K | n/a | Feb 18, 26 |
Spiegel Robert J. Director | Acquired (grant/award) | +6K | added 3.1% | 194K | $8K at $1.32 | Dec 31, 25 |
Spiegel Robert J. Director | Acquired (grant/award) | +6K | added 3.1% | 189K | $8K at $1.37 | Sep 30, 25 |
Spiegel Robert J. Director | Acquired (grant/award) | +6K | added 3.1% | 183K | $8K at $1.41 | Jun 30, 25 |
Lawlis V Bryan Director | Bought (open market) | +13K | n/a | 13K | $16K at $1.18 | May 9, 25 |
Spiegel Robert J. Director | Acquired (grant/award) | +5K | added 2.8% | 177K | $8K at $1.59 | Mar 31, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on GERN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GERN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
GERN last traded at $0.906, down 0.81% on the day and down 0.81% pre-market. The price and chart above update live during market hours (4 AM to 8 PM ET).
The GERN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GERN 202 times in the last 30 days.
GERN (Geron Corp) trades on XNAS, with a market cap of about $588M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GERN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GERN discussion
Sign in to ask a question or join the discussion.